［1］   Simpson JL. Genetic and phenotypic heterogeneity in ovarian failure：overview of selected candidate genes［J］. Ann NY Acad Sci，2008，1135：146-154.

［2］   Persani L，Rossetti R，Cacciatore C. Genes involved in human premature ovarian failure［J］. Mol Endocrinol，2010，45（5）：257-279.

［3］   Kalantaridou SN，Nelson LM. Premature ovarian failure is not premature menopause［J］. Ann N Y Acad Sci，2000，900（3）：393-402.

［4］   Molina JR，Barton DL，Loprinzi CL. Chemotherapy-induced ovarian failure：manifestations and management［J］. Drug Saf，2005，28（5）：401-416.

［5］   Hubayter ZR，Popat V，Vanderhoof VH，et al. A prospective evaluation of antral follicle function in women with 46，XX spontaneous primary ovarian insufficiency［J］. Fertil Steril，2010，94：1769-1774.

［6］   Michael P，David A，Rossi G，et al. Counter-regulatory response to hypoglycemia in the follicular and lutel phases of the menstrual cycle［J］. Fertil Steril，1993，59（5）：988.

［7］   Kalu E，Panay N. Spontaneous premature ovarian failure：management challenge［J］. Gynecol Endocrinol，2008，24（5）：273-279.

［8］   Tomao F，Spinelli GP，Panici PB，et al. Ovarian function，reproduction and strategies for fertility preservation after breast cancer［J］. Crit Rev Oncol Hematol，2010，76：1-12.

［9］   Blumenfeld ZL，Evron A. Preserving fertility when choosing chemotherapy regimens-the role of gonadotropin-releasing hormone agonists［J］. Expert Opin Pharmacother，2015，31：1-12.

［10］   Tartagni M，Cicinelli E，De Pergola G，et al. Effects of pretreatment with estrogens on ovarian stimulation with gonadotropins in women with premature ovarian failure：a randomized，placebo-controlled trial［J］. Fertil Steril，2007，87：858-861.

［11］   Bidet M，Bachelot A，Bissauge E，et al. Resumption of ovarian function and pregnancies in 358 patients with premature ovarian failure［J］. J Clin Endocrinol Metab，2011，96（12）：3864-3872.

［12］   Blumenfeld Z. Fertility treatment in women with premature ovarian failure［J］. Expert Rev Obstet Gynecol，2011，6（3）：321-330.

［13］    庄广伦，李洁，周灿权，等. 援供卵治疗卵巢早衰妊娠成功（附一例报告）［J］.中山医科大学学报，1994，16（1）：66.

［14］    Karine C，Jacques D，Elizabeth G，et al. Emergency IVF versus ovarian tissue cryopreservation：decision making in fertility preservation for female cancer patients［J］. Fertil Steril，2013，99（6）：1534-1542.

［15］   Lawrenz B，Jauckus J，Kupka M，et al. Efficacy and safety of ovarian stimulation before chemotherapy in 205 cases［J］. Fertil Steril，2010，94：2871-2873.

［16］    Dolmans MM，Donnez J，Camboni A，et al. IVF outcome in patients with orthotopically transplanted ovarian tissue［J］. Hum Reprod，2009，24：2778-2787.

［17］    Schmidt KT，Rosendahl M，Ernst E，et al. Autotransplantation of cryopreserved ovarian tissue in 12 women with chemotherapy-induced premature ovarian failure：the Danish experience［J］. Fertil Steril，2011，95（2）：695-701.

［18］   Roesner S，Von woIff M，Eberhardt I，et al. In vitro maturation：a five-year experience［J］. Acta Obstet Gynecol Scand，2012，91：22-27.

［19］   Geynberg M，Poulain M，Sebag-peyrelevade S，et al. Ovarian tissue and follicle transplantation as an option for fertility preservation［J］. Fertil Steril，2012，97（6）：1260-1268.

［20］   Tremellen KP，Kolo M，Gilmore A，et al. Anti-Mullerian hormone as a marker of ovarian reserve［J］. Australian and New Zealand J Obstet Gynecol，2005，45（1）：20-24.

［21］    覃春容，陈士岭，陈薪，等. 特发性卵巢早衰的临床特点分析［J］.南方医科大学学报，2011，31（5）：886-889.

［22］   Harel S，Ferme C，Poirot C. Management of fertility in patients treated for Hodgkin’s lymphoma［J］. Haematologica，2011，96：1692-1699．

［23］   Badosehi GM，de Albuquerque FO，Ferriani RA，et al. Ovarian stimulation during the luteal phase for fertility preservation of cancer patients：case reports and review of the literature［J］. J Assist Reprod Genet，2010，27：491-494．

（2015-03-04收稿    2015-04-16修回）